Post autologous transplant (autoHCT)therapies in high risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT followed by lenalidomide maintenance(Len)(AM) vs auto HCT and Len and bortezomib (BZ) and dexamethasone consolidation Len maintenance(ACM) vs tandem autoHCT Len maintenance Meeting Abstract


Authors: Krishnan, A.; Pasquini, M.; Blackwell, B.; Knust, K.; Bashey, A.; Devine, S.; Efebera, Y.; Ganguly, S.; Gasparetto, C.; Geller, N.; Giralt, S.; Parameswaran, H.; Horowitz, M.; Koreth, J.; Landau, H.; McCarthy, P.; McClune, B.; Nelson, C.; Qazilbash, M.; Shah, N.
Abstract Title: Post autologous transplant (autoHCT)therapies in high risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT followed by lenalidomide maintenance(Len)(AM) vs auto HCT and Len and bortezomib (BZ) and dexamethasone consolidation Len maintenance(ACM) vs tandem autoHCT Len maintenance
Meeting Title: 16th International Myeloma Workshop
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 17
Issue: 1 Suppl.
Meeting Dates: 2017 Mar 1-4
Meeting Location: New Delhi, India
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2017-02-01
Start Page: e5
Language: English
ACCESSION: 122646535
DOI: 10.1016/j.clml.2017.03.009
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Meeting Abstract: OP-008 -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1063 Giralt
  2. Heather Jolie Landau
    428 Landau